WHO ICTRP trial
A Phase 2b study for adults hospitalized with Respiratory Syncytial Virus.
EUCTR2016-001653-40-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-001653-40-GB |
|---|---|
| Public title | A Phase 2b study for adults hospitalized with Respiratory Syncytial Virus. |
| Scientific title | A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered ALS-008176 Regimens in Adult Subjects Hospitalized with Respiratory Syncytial Virus - A Phase 2b study for adults… |
| Primary sponsor | Janssen-Cilag International NV |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Taiwan;Spain;United Kingdom;France;Mexico;Canada;Argentina;Poland;Malaysia;Belgium;Brazil;Singapore;Australia;Bulgaria;Netherlands;Germany;Japan;Korea, Republic of;Sweden |
| Conditions | Respiratory Syncytial Virus Infection MedDRA version: 20.1 Level: PT Classification code 10061603 Term: Respiratory syncytial virus infection System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus… |
| Interventions | Product Name: ALS-008176 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Lumicitabine CAS Number: 1445385-02-3 Current Sponsor code: ALS-008176 Other descriptive name: JNJ-64041575-AAA Concentration unit: mg milligram(s)… |
| Registration date | Jun 28, 2016 |
| Target size | 218 |
| Secondary IDs | 64041575RSV2003 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: